Analysis of run-in and treatment data in a wound outcomes registry: Clinical impact of topical platelet-rich plasma gel on healing trajectory

International Wound Journal

Volumn 8, Issue 6, 2011, Pages 638-650

  Carter, Marissa J ^a   Fylling, Carelyn P ^b   Li, William W ^c   de Leon, Jean ^d   Driver, Vickie R ^e   Serena, Thomas E ^f   Wilson, Janice ^g  

^a Strategic Solutions Inc   (United States)

^b CLNC   (United States)

^c The Angiogenesis Foundation   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f The Serena Group   (United States)

^g Asheville Specialty Hospital   (United States)

Author keywords

Clinical study; Platelet rich plasma; Practice based evidence; Statistical analysis; Wound healing

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC WOUND; DISEASE REGISTRY; EVIDENCE BASED PRACTICE; FEMALE; GEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE RICH PLASMA; TREATMENT OUTCOME; VALIDATION STUDY; WOUND CARE; WOUND HEALING;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; PLATELET-RICH PLASMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; TREATMENT OUTCOME; VARICOSE ULCER; WOUND HEALING;

EID: 81155148171     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2011.00868.x     Document Type: Article

References (34)

1. Lau J, Tatsioni A, Balk E, Chew P, Kupelnick B, Wang C, O'Donnell T. Usual care in the management of chronic wounds: A review of the recent literature. Agency for Healthcare Research and Quality Technology Assessment Program. Rockville, MD: Department of Health and Human Services, 2005 March 8.
2. Falanga V. The chronic wound: failure to heal. In: Falanga V, editor. Cutaneous wound healing. Florence: Martin Dunitz Ltd., 2001:155-64.
3. Fowler E. Chronic wounds: an overview. In: Krasner D, editor. Chronic wound care, a clinical source book for healthcare professionals. King of Prussia: Health Management Publications Inc, 1990:12-8.
4. Robson MC, Barbul A. Guidelines for the best care of chronic wounds. Wound Repair Regen 2006;14:647-8.
5. Lawrence WT. Clinical management of nonhealing wounds. In: Cohen IK, Diegelmann RF, Lindblad WJ, editors. Wound healing: biochemical and clinical aspects. Philadelphia: Saunders, 1992:541-61.
6. Steed DL, Attinger C, Colaizzi T, Crossland M, Franz M, Harkless L, Johnson A, Moosa H, Robson M, Serena T, Sheehan P, Veves A, Wiersma-Bryant L. Guidelines for the treatment of diabetic ulcers. Wound Repair Regen 2006;14:680-92.
7. Robson MC, Cooper DM, Aslam R, Gould LJ, Harding KG, Margolis DJ, Ochs DE, Serena TE, Snyder RJ, Steed DL, Thomas DR, Wiersma-Bryant L. Guidelines for the treatment of venous ulcers. Wound Repair Regen 2006;14:649-62.
8. Whitney J, Phillips L, Aslam R, Barbul A, Gottrup F, Gould L, Robson MC, Rodeheaver G, Thomas D, Stotts N. Guidelines for the treatment of pressure ulcers. Wound Repair Regen 2006;14:663-79.
9. Carter MJ, Fife CE. Factors affecting the healing of chronic wounds: an iconoclastic view. In: Percival SL, editor. Microbiology of chronic wounds. London: CRC Press, 2010:345-72.
10. Tallman P, Muscare E, Carson P, Eaglstein WH, Falanga V. Initial rate of healing predicts complete healing of venous ulcers. Arch Dermatol 1997;133:1231-4.
11. Kantor J, Margolis DJ. A multicentre study of percentage change in venous leg ulcer area as a prognostic index of healing at 24 weeks. Br J Dermatol 2000;142:960-4.
12. Weingarten MS, Neidrauer M, Mateo A, Mao X, McDaniel JE, Jenkins L, Bouraee S, Zubkov L, Pourrezaei K, Papazoglou ES. Prediction of wound healing in human diabetic foot ulcers by diffuse near-infrared spectroscopy: a pilot study. Wound Repair Regen 2010;18:180-5.
13. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 2003;26:1879-82.
14. Jacobson M, Fufa D, Abreu EL, Kevy S, Murray MM. Platelets, but not erythrocytes, significantly affect cytokine release and scaffold contraction in a provisional scaffold model. Wound Repair Regen 2008;16:370-8.
15. Driver VR, Hanft J, Fylling CP, Beriou JM, AutoloGelTM Diabetic Foot Ulcer Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 2006;52:68-87.
16. Frykberg RG, Driver VR, Carman D, Lucero B, Borris-Hale C, Fylling CP, Rappl LM, Clausen PA. Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series. Ostomy Wound Manage 2010;56:36-44.
17. Reese RJ. Autologous platelet rich plasma (PRP): what do we know? Important concepts relevant to hair restoration surgery. Hair Transplant Forum International 2010;20:14-17.
18. FDA 510(k) clearance, BK060007. AutoloGel System. Rockville (MD): Cytomedix, Inc, 2007.
19. Horn SD, Gassaway J. Practice-based evidence study design for comparative effectiveness research. Med Care 2007;45:S50-7.
20. A EWMA patient outcome group document. Outcomes in controlled and comparative studies on non-healing wounds; recommendations to improve the quality of evidence in wound management. J Wound Care 2010;19:239-68.
21. Bagshaw SM, Bellomo R. The need to reform our assessment of evidence from clinical trials: a commentary. Philos Ethics Humanit Med 2008;3:23.
22. Moffatt CJ, Doherty DC, Smithdale R, Franks PJ. Clinical predictors of leg ulcer healing. Br J Derm 2010;162:51-8.
23. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92.
24. U.S. Department of Health and Human Service. National Institutes of Health. HIPAA Privacy Rule. URL : [accessed on 8 December 2010].
25. Sussman C. Wound measurements. In: Sussman C, Bates-Jensen B, editors. Wound care: a collaborative practice manual for physical therapists and nurses. Gaithersburg: Aspen, 2001:120-41.
26. Margolis DJ, Kantor J, Berlin JA. Healing of diabetic neuropathic ulcers receiving standard treatment. A meta-analysis. Diabetes Care 1999;22:692-95.
27. Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care 2008;31:631-36.
28. Hill T, Lewicki P. Statistics: general linear models. Methods and Applications. Tulsa: StatSoft, 2007:245-6.
29. Lockhart AC, Braun RD, Yu D, Ross JR, Dewhirst MW, Humphrey JS, Thompson S, Williams KM, Kiltzman B, Yuan F, Grichnik JM, Prola AD, Conway DA, Hurwitz HI. Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin Cancer Res 2003;9:586-93.
30. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1998;21:855-9.
31. Lavery L, McGuire J, Baranoski S, Ayello EA. Diabetic foot ulcers. In: Baranoski S, Ayello EA, editors. Wound care essentials: practice principles. Ambler, PA: Lippincott Williams & Wilkins, 2006:338-62.
32. Dougherty EJ. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Adv Skin Wound Care 2008;21:568-75.
33. Manchikanti L, Singh V, Derby R, Schultz DM, Benyamin RM, Prager JP, Hirsch JA. Reassessment of evidence synthesis of occupational medicine practice guidelines for interventional pain management. Pain Physician 2008;11: 393-482.
34. de Leon JM, Driver VR, Fylling CP, Carter MJ, Anderson C, Wilson J, Dougherty RM, Fuston D, Trigilia D, Valenski V, Rappl LM. The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel. Adv Skin Wound Care 2011;24:357-68.